Opto cell line development workflow on the Beacon platform
14 Sept 2026Cell line development (CLD) teams need to identify productive, stable clones without allowing lengthy screening and expansion workflows to delay the progression of promising protein therapeutics.
This brochure introduces the Opto® Cell Line Development workflow on the Beacon® platform, covering single-cell cloning, monoclonality assurance and early assessment of productivity and product quality. It also outlines approaches for compressing development timelines, characterizing clones through a broad assay portfolio, and creating reproducible, automated workflows.
Discover how Opto® CLD can help teams select promising production clones earlier, reduce downstream screening requirements, and shorten the route from transfection to lead clone selection.
Resource details:
Resource type: Product brochure
Page count: 5 pages
Read time: 8 mins
